Skip to main content
. Author manuscript; available in PMC: 2020 Sep 24.
Published in final edited form as: Circ Res. 2020 Jul 30;127(8):997–1022. doi: 10.1161/CIRCRESAHA.120.317295

Table 1.

Cytoskeletal, Cell Adhesion, and Extracellular Matrix Proteins with Significantly Different Abundance in Aortas of SR-uPA+/0 Mice

Cytoskeletal Proteins*
Increased in SR-uPA+/0 aortas
Cell Adhesion Proteins
Increased in SR-uPA+/0 aortas
Extracellular Matrix Proteins
Decreased in SR-uPA+/0 aortas
Protein SR-uPA+/0 SR-uPA0/0 Protein SR-uPA+/0 SRuPA0/0 Protein SR-uPA+/0 SR-uPA0/0
ARPC1B 7.4 ± 2.5 1.6 ± 0.6 HDLBP 9 ± 3.3 1.9 ± 1.4 EMILIN1 3.2 ± 1.7 11.5 ± 2.9
CAPZB 11 ± 2.5 5.8 ± 1.7 ACTB 57.1 ± 6.8 42.9 ± 8 LTBP4 17.9 ± 5 40.4 ± 4.3
CFL1 15.8 ± 2.7 9.9 ± 1.2 ARPC1B 7.4 ± 2.5 1.6 ± 0.6 AGRN 9.3 ± 2.7 21.3 ± 2.4
MYH9 42.6 ± 10.1 22.7 ± 5.6 CAPZB 11 ± 2.5 5.8 ± 1.7 ATP5B 70.4 ± 8.1 95.9 ± 13
LCP1 10.3 ± 1.1 6.2 ± 2.2 CFL1 15.8 ± 2.7 9.9 ± 1.2 COL15A1 18.3 ± 5.1 29.8 ± 5.8
SPTBN1 14.4 ± 4.5 4.1 ± 1.6 EEF2 18 ± 2.2 10.7 ± 3.7 COL1A2 12.2 ± 3.5 18.2 ± 2.9
CORO1C 3.9 ± 1.1 1.5 ± 1.3 GNB2 9.5 ± 1.8 4.3 ± 0.3 ELN 8.7 ± 2.9 15 ± 2.5
FLNB 9.3 ± 1.1 2.1 ± 1.4 PDIA3 46.5 ± 4.5 36.6 ± 4.7 FN1 309.3 ± 35.9 399.7 ± 40.9
SEPT9 3 ± 0.9 0.5 ± 0.8 RPS2 10.3 ± 1.6 6.2 ± 1.2 HSPG2 207.4 ± 16.3 272.8 ± 17.5
ACTN4 28.7 ± 2.3 14.5 ± 2.4 ANXA1 28.9 ± 3.4 22.2 ± 3.1 LAMA5 16.4 ± 2.2 35.8 ± 7.8
AHNAK 54.2 ± 9.7 36.2 ± 6.7 LRP1 16.2 ± 3.4 7.8 ± 0.4 LAMB2 53.2 ± 5.3 70.7 ± 5
ACTB 57.1 ± 6.8 42.9 ± 8 MYH9 42.6 ± 10.1 22.7 ± 5.6 LOXL1 38.9 ± 3.2 58.9 ± 8.4
MAP4 4.7 ± 3 0.4 ± 0.6 PLAU 17.4 ± 6.5 0 ± 0 NID1 39.6 ± 5.3 64.3 ± 7.7
PLEC 25.8 ± 2.3 7.8 ± 2.2 PLEC 25.8 ± 2.3 7.8 ± 2.2 NID2 21.9 ± 3.3 31.5 ± 1.3
TCP1 15.1 ± 1.9 8.2 ± 2.7 LCP1 10.3 ± 1.1 6.2 ± 2.2 EFEMP1 2.5 ± 1.2 11.8 ± 4.1
MVP 21.5 ± 3.4 12.2 ± 3.2 RPS5 4.3 ± 1.3 1.9 ± 0.7 SERPINE2 8.9 ± 3 16.9 ± 2.2
RCC1 4.1 ± 1 1.8 ± 1.4 SPTBN1 14.4 ± 4.5 4.1 ± 1.6 VTN 17.9 ± 4.2 25.3 ± 3.9
ANXA1 28.9 ± 3.4 22.2 ± 3.1 THY1 2.8 ± 0.6 0.7 ± 0.9 WISP2 6.4 ± 2.3 10.8 ± 2
THY1 2.8 ± 0.6 0.7 ± 0.9 HSP90B1 41.6 ± 2.6 24.7 ± 5.3 FBLN5 46.5 ± 5.6 80.1 ± 10.5
HSP90B1 41.6 ± 2.6 24.7 ± 5.3 CORO1C 3.9 ± 1.1 1.5 ± 1.3 POSTN 51.4 ± 5.3 63.2 ± 3.7
ANXA8 8.5 ± 2.3 3.7 ± 1.2 FLNB 9.3 ± 1.1 2.1 ± 1.4 HTRA1 13.5 ± 6.7 29.8 ± 2.5
EEF2 18 ± 2.2 10.7 ± 3.7 SEPT9 3 ± 0.9 0.5 ± 0.8 MFAP4 36 ± 5.9 47.4 ± 6
GNB1 13.4 ± 2.2 3.9 ± 1.1 SND1 10.1 ± 5.4 2.8 ± 1.2 PLG 10.3 ± 6.6 22.2 ± 5.6
VCP 31.3 ± 5.8 19 ± 4 ACTN4 28.7 ± 2.3 14.5 ± 2.4 BCAM 5.5 ± 3.5 12 ± 3.1
AHNAK 54.2 ± 9.7 36.2 ± 6.7 LAMC1 50.5 ± 5.9 64.2 ± 6.4
RPL4 16.7 ± 2.1 11.5 ± 2.5
PUF60 5.8 ± 1.2 3 ± 1.2
DDOST 10.9 ± 3 5.5 ± 2

Data are mean ± SD. All differences were significant (FDR< 0.05; Online Data Set II)

*

Includes all proteins in GO categories: 0015629 (actin cytoskeleton), 0030863 (cortical cytoskeleton), 0005856 (cytoskeleton), 0007010 (cytoskeleton organization), or 0008092 (cytoskeletal protein binding).

Includes all proteins in GO categories: 005912 (adherens junction), 005925 (focal adhesion), or 0007155 (cell adhesion).

Includes all proteins in GO categories: 0031012 (extracellular matrix), 00030198 (extracellular matrix organization), 0050840 (extracellular matrix binding), 0005201 (extracellular matrix structural constituent, or 0005604 (basement membrane; these are in bold type).